These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29758555)

  • 1. Secondary Prevention Three and Six Years after Stroke Using the French National Insurance Healthcare System Database.
    Mechtouff L; Haesebaert J; Viprey M; Tainturier V; Termoz A; Porthault-Chatard S; David JS; Derex L; Nighoghossian N; Schott AM
    Eur Neurol; 2018; 79(5-6):272-280. PubMed ID: 29758555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater Adherence to Secondary Prevention Medications Improves Survival After Stroke or Transient Ischemic Attack: A Linked Registry Study.
    Dalli LL; Kim J; Cadilhac DA; Greenland M; Sanfilippo FM; Andrew NE; Thrift AG; Grimley R; Lindley RI; Sundararajan V; Crompton DE; Lannin NA; Anderson CS; Whiley L; Kilkenny MF
    Stroke; 2021 Nov; 52(11):3569-3577. PubMed ID: 34315251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prescription at discharge improves long-term adherence for secondary stroke prevention.
    Tsai JP; Rochon PA; Raptis S; Bronskill SE; Bell CM; Saposnik G
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2308-15. PubMed ID: 25149205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recording a diagnosis of stroke, transient ischaemic attack or myocardial infarction in primary healthcare and the association with dispensation of secondary preventive medication: a registry-based prospective cohort study.
    Dahlgren C; Geary L; Hasselström J; Rehnberg C; Schenck-Gustafsson K; Wändell P; Euler MV
    BMJ Open; 2017 Sep; 7(9):e015723. PubMed ID: 28939569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention after stroke/transient ischemic attack: A randomized audit and feedback trial.
    Geary L; Hasselström J; Carlsson AC; Eriksson I; von Euler M
    Acta Neurol Scand; 2019 Aug; 140(2):107-115. PubMed ID: 31017305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Few sex differences in the use of drugs for secondary prevention after stroke: a nationwide observational study.
    Sjölander M; Eriksson M; Glader EL
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):911-9. PubMed ID: 22069216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary-prevention drug prescription in the very elderly after ischemic stroke or TIA.
    Ovbiagele B; Hills NK; Saver JL; Johnston SC
    Neurology; 2006 Feb; 66(3):313-8. PubMed ID: 16476928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke.
    Glader EL; Sjölander M; Eriksson M; Lundberg M
    Stroke; 2010 Feb; 41(2):397-401. PubMed ID: 20075360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics and prevention among patients with stroke: a study of 36,844 patients hospitalized in France].
    Tuppin P; Moysan V; de Peretti C; Schnitzler A; Fery-Lemonnier E; Woimant F
    Rev Neurol (Paris); 2013 Feb; 169(2):126-35. PubMed ID: 22749335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of medication nonadherence on stroke recurrence and mortality in patients after first-ever ischemic stroke: Insights from registry data in Singapore.
    Yeo SH; Toh MPHS; Lee SH; Seet RCS; Wong LY; Yau WP
    Pharmacoepidemiol Drug Saf; 2020 May; 29(5):538-549. PubMed ID: 32190948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke Risk Factor Status and Use of Stroke Prevention Medications Among Hispanic/Latino Adults in HCHS/SOL.
    Bai F; Chen J; Pandey D; Durazo-Arvizu R; Talavera GA; Allison MA; Perreira KM; Schneiderman N; Sutherland MW; Cai J; Daviglus ML; Testai FD
    Stroke; 2021 Apr; 52(4):1339-1346. PubMed ID: 33657859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sociodemographic factors are associated with utilisation of statins after ischaemic stroke/TIA.
    Geary L; Aronius J; Wettermark B; Hasselström J; Sjöborg B; von Euler M
    Int J Clin Pract; 2017 Mar; 71(3-4):. PubMed ID: 28371022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicines taken by older Australians after transient ischaemic attack or ischaemic stroke: a retrospective database study.
    Sluggett JK; Caughey GE; Ward MB; Gilbert AL
    Int J Clin Pharm; 2015 Oct; 37(5):782-9. PubMed ID: 25920907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prevention in patients with vascular disease. A population based study on the underuse of recommended medications.
    Béjot Y; Zeller M; Lorgis L; Troisgros O; Aboa-Eboulé C; Osseby GV; Giroud M; Cottin Y
    J Neurol Neurosurg Psychiatry; 2013 Mar; 84(3):348-53. PubMed ID: 23152636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First hospitalization for transient ischemic attack in France: Characteristics, treatments and 3-year outcomes.
    Cosker K; Samson S; Fagot-Campagna A; Woimant F; Tuppin P
    Rev Neurol (Paris); 2016 Feb; 172(2):152-9. PubMed ID: 26318894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of medications for secondary prevention in stroke patients at hospital discharge in Australia.
    Eissa A; Krass I; Bajorek BV
    Int J Clin Pharm; 2014 Apr; 36(2):384-93. PubMed ID: 24519632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey on adherence to secondary ischemic stroke prevention.
    Wang Y; Wu D; Wang Y; Ma R; Wang C; Zhao W
    Neurol Res; 2006 Jan; 28(1):16-20. PubMed ID: 16464357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of secondary prevention medication and related factors for acute ischemic stroke and transient ischemic attack in China.
    Jiang Y; Yang X; Li Z; Pan Y; Wang Y; Wang Y; Ji R; Wang C
    Neurol Res; 2017 Jun; 39(6):492-497. PubMed ID: 28420316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary stroke prevention: practice patterns in a tertiary care stroke service.
    Fan JC; Mysak TM; Jeerakathil TJ; Pearson GJ
    Can J Neurol Sci; 2010 Mar; 37(2):245-51. PubMed ID: 20437937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin Adherence After Ischemic Stroke or Transient Ischemic Attack Is Associated With Clinical Outcome.
    Chen PS; Cheng CL; Kao Yang YH; Li YH
    Circ J; 2016; 80(3):731-7. PubMed ID: 26742588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.